Phase 1 Acute Lymphoblastic Leukemia, Adult B-Cell Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

Acute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in Relapse

Essen Biotech75 enrolled1 locationNCT06213636

Recruiting

Phase 1Phase 2

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia, Adult B-Cell

The First Affiliated Hospital of Soochow University34 enrolled1 locationNCT03984968

Recruiting

Phase 1

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Hematologic MalignancyGvHDGVHD,Acute+8 more

Tr1X, Inc.36 enrolled5 locationsNCT06462365